Summit X, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Summit X, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2023$236,553
+13.9%
2,344
+3.8%
0.06%
+5.6%
Q1 2023$207,756
+2.6%
2,258
-5.7%
0.05%
-8.5%
Q4 2022$202,522
-0.7%
2,395
-0.0%
0.06%0.0%
Q2 2022$204,000
-2.9%
2,396
+0.9%
0.06%
+13.5%
Q1 2022$210,000
+5.0%
2,374
+4.4%
0.05%
+10.6%
Q4 2021$200,000
-4.3%
2,273
-1.5%
0.05%
-11.3%
Q2 2021$209,000
+0.5%
2,307
-3.9%
0.05%
-7.0%
Q1 2021$208,000
-8.0%
2,401
+0.4%
0.06%
-14.9%
Q4 2020$226,000
-91.9%
2,392
-4.9%
0.07%
+45.7%
Q3 2020$2,783,000
+1194.4%
2,515
+2.0%
0.05%
-41.8%
Q2 2020$215,0002,4650.08%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders